4-{[{3-chloro-4-[cyclopropyl(difluoro)methyl]benzyl}(1-cyclopropyl-4-methylisoquinolin-3-yl)amino]sulfonyl}benzoic acid | 1400700-41-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 4-{[{3-chloro-4-[cyclopropyl(difluoro)methyl]benzyl}(1-cyclopropyl-4-methylisoquinolin-3-yl)amino]sulfonyl}benzoic acid
• 英文别名: 4-[[3-Chloro-4-[cyclopropyl(difluoro)methyl]phenyl]methyl-(1-cyclopropyl-4-methylisoquinolin-3-yl)sulfamoyl]benzoic acid
• CAS: 1400700-41-5
• 化学式: C₃₁H₂₇ClF₂N₂O₄S
• 分子量: 597.082
• InChiKey: OWRMBNVULAPTPT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.9
• 重原子数：
  41
• 可旋转键数：
  9
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  96
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• SULFONAMIDE COMPOUNDS HAVING TRPM8 ANTAGONISTIC ACTIVITY
  申请人：Tsuzuki Yasuyuki

  公开号：US20140005393A1

  公开（公告）日：2014-01-02

  Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof: (I) wherein Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine is condensed with benzene; or (b) pyridine is condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of the pyridine ring constituting Ring A, Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle, Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle, and other symbols are the same as defined in the specification.

  提供具有TRPM8拮抗活性的磺胺类化合物。提供式(I)的磺胺类化合物或其药学上可接受的盐或前药，其中，环A是由(a)吡啶与苯环缩合；或(b)吡啶与单环芳杂环缩合构成的双环芳香杂环，环A与构成环A的吡啶环上的氮原子相邻的碳原子上的磺酰氨基团结合，环B为(a)单环或双环芳香烃；(b)单环或双环脂环烃；(c)单环或双环芳杂环；或(d)单环或双环非芳杂环，环C为(a)苯环；或(b)单环芳杂环，其他符号与规范中定义的相同。
• Compositions for treating or preventing vasomotor symptoms
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：US10993939B2

  公开（公告）日：2021-05-04

  The present disclosure is directed to compositions and methods for treating or preventing vasomotor symptoms such as hot flashes, comprising a Transient Receptor Potential Melastatin 8 (TRPM8) antagonist and administering a TRPM8 antagonist, respectively.

  本公开涉及用于治疗或预防潮热等血管运动症状的组合物和方法，分别包括瞬时受体电位美拉辛8（TRPM8）拮抗剂和给药TRPM8拮抗剂。
• COMPOSITIONS FOR TREATING OR PREVENTING VASOMOTOR SYMPTOMS
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP3468557A1

  公开（公告）日：2019-04-17
• US8987445B2
  申请人：——

  公开号：US8987445B2

  公开（公告）日：2015-03-24
• US9540360B2
  申请人：——

  公开号：US9540360B2

  公开（公告）日：2017-01-10